The platform will undergo maintenance on Sep 14 at about 7:45 AM EST and will be unavailable for approximately 2 hours.
2014
DOI: 10.1016/j.ejmech.2014.07.049
|View full text |Cite
|
Sign up to set email alerts
|

Identification of constrained peptidomimetic chemotypes as HIV protease inhibitors

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
5
0

Year Published

2014
2014
2023
2023

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 9 publications
(5 citation statements)
references
References 27 publications
(38 reference statements)
0
5
0
Order By: Relevance
“…Additionally these compounds satisfy all the requirements needed for the peptidomimetic chemistry, as they are easily synthesized and decorated with functional groups, and are well-suited for solid-phase synthesis. These scaffolds revealed to be active hit compounds towards different targets, as they have been used as aspartyl protease inhibitors [84,85] and NGF-agonists [86].…”
Section: Case Study 3: Our Contribution To the Chemical Genetics Smentioning
confidence: 99%
“…Additionally these compounds satisfy all the requirements needed for the peptidomimetic chemistry, as they are easily synthesized and decorated with functional groups, and are well-suited for solid-phase synthesis. These scaffolds revealed to be active hit compounds towards different targets, as they have been used as aspartyl protease inhibitors [84,85] and NGF-agonists [86].…”
Section: Case Study 3: Our Contribution To the Chemical Genetics Smentioning
confidence: 99%
“…A library of 6,8-dioxa-3-azabicyclo[3.2.1]-octane peptidomimetic scaffolds was screened against HIV protease, resulting in the identification of hit compounds possessing IC 50 values in the sub-micromolar range, and showing the bicyclic acetal portion as a potential transition state analogue in the interaction with catalytic aspartic acid residues [13].…”
Section: Library Applicationsmentioning
confidence: 99%
“…Peptidomimetic inhibitors are capable of interacting with biological targets and producing the same therapeutic effects as native peptides. Using peptidomimetic inhibitors can eliminate some of the drawbacks of using native peptides, including proteolysis and low bioavailability (Vankadara et al 2021 ; Paul et al 2021 ; Somboon et al 2021 ; Wang et al 2022 ; Phoo et al 2018 ; Colarusso et al 2022 ; Ezat et al 2015 ; Mostafa et al 2014 ; Ibrahim et al 2013 ; Saleh and Elshemey 2017 ; Calugi et al 2014 ; Frecer et al 2008 ).…”
Section: Introductionmentioning
confidence: 99%